Navigation Links
Spectrum Announces bioWorld Distribution Agreement
Date:2/6/2013

New Brunswick, NJ (PRWEB) February 06, 2013

Spectrum Chemicals & Laboratory Products has become a premier distributor for bioWorld, an internationally recognized manufacturer of bioaffinity matrices and reagents for proteomics research. This agreement provides Spectrum access to one of the most comprehensive line of life sciences and biotechnology products for research, including affinity chromatography, molecular biology, cell culture and microbiological reagents.

Spectrum’s major emphasis is on active pharmaceutical ingredients and controlled substances, excipients, dietary supplements, cosmetic ingredients, biochemicals, and a complete line of high-purity solvents for critical analytical applications. "The addition of bioWorld’s Separopore® bioAffinity Matrices for Protein Purification and related buffers and reagents for proteomics expands Spectrum’s current footprint in analytical applications, with a wide range of protein purification reagents not available in the market place. bioWorld’s line of research reagents gives Spectrum access to one of the most comprehensive lines of life sciences and biotechnology products for research, including affinity chromatography, molecular biology, cell culture and microbiology", says Mark Hurd, Spectrum’s General Manager. He adds, "We are committed to increasing our profile across all aspects of life science research from buffers and reagents to high-quality, easy-to-use research kits."

About Spectrum Chemicals & Laboratory Products
Founded in 1971, Spectrum Chemicals & Laboratory Products manufactures and distributes fine chemicals for production and laboratory facilities around the globe. All of Spectrum's worldwide facilities are ISO 900
'/>"/>

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2

Related biology technology :

1. Cempra Inc. Presents Additional Data on the Clinical Profile and Activity Spectrum of Solithromycin at the Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC)
2. Virobays Spectrum-Selective Cathepsin Inhibitor Shows Efficacy in Bone Cancer Model
3. Life Technologies Announces Fourth Quarter and Fiscal 2012 Results
4. United Therapeutics Announces Additional $420 Million Share Repurchase Program
5. Glenmark Announces a New Discovery and the Initiation of IND Enabling Studies of a Novel Monoclonal Antibody Targeting OX40
6. Patheon Announces First Phase of Additional Investment in Milton Park, UK Facility to Expand Early Development Capabilities in Europe
7. Governor Cuomo Announces Continued Growth at Roswell Park Cancer Institute with Regional Economic Development Council Funding; RPCI Center for Personalized Medicine established with CTG (NASDAQ: CTGX) serving as its technology partner
8. Undiscovered Companies Announces A Video Interview Of Hidden Bio-Tech Company Immunotech Laboratories
9. Sangamo BioSciences Announces Fourth Quarter And Full Year 2012 Conference Call And Webcast
10. ComplianceOnline Announces Seminar on Statistical Analysis for Product Development
11. Navigating Cancer Announces Jeff Oberlander as VP, Engineering
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/1/2015)... and PARIS , July 1, ... Genective, key developer of biotech crops, today announce ... new generations of insect control traits. ... counter the realities of advancing insect resistance. We ... unique insect control technology with Genective,s capability in ...
(Date:7/1/2015)... 2015  Axovant Sciences Ltd. (NYSE:  AXON), a ... of dementia, today announced that the company will ... 5:45 p.m. EDT following its presentation of RVT-101 ... 2015 (AAIC). The event will ... Lawrence Friedhoff , Chief Development Officer, will ...
(Date:7/1/2015)... ... July 01, 2015 , ... NEMA 4 (IP66) Medical Joysticks ... Medical Joysticks have an impermeable molecular barrier protection against bio-hazardous agents. Original ... will increase healthcare worker safety and reduce financial costs. , CTI Electronics announces ...
(Date:6/30/2015)... ... 30, 2015 , ... Park Systems , world-leader in ... into new classes of Nanoscale Graphene-based materials poised to revolutionize industries such as ... of the 21st Century' by the researchers who were awarded the 2010 Nobel ...
Breaking Biology Technology:AgBiome and Genective collaborate to create novel insect-resistant crops 2Axovant Sciences To Host Investor Briefing And Live Webcast During AAIC 2015 Meeting 2Axovant Sciences To Host Investor Briefing And Live Webcast During AAIC 2015 Meeting 3Sanitized Medical Joysticks for a Safer and Healthier Work Environment 2How Graphene–based Nanomaterials and Films Revolutionize Science Explained in July 9 Webinar Hosted by Park Systems 2How Graphene–based Nanomaterials and Films Revolutionize Science Explained in July 9 Webinar Hosted by Park Systems 3How Graphene–based Nanomaterials and Films Revolutionize Science Explained in July 9 Webinar Hosted by Park Systems 4
... SAN DIEGO, Jan. 6, 2011 Ardea Biosciences, Inc. ... top-line results from its Phase 2b study of RDEA594 ... the treatment of gout, allopurinol.  Allopurinol currently accounts for ... gout prescription medications; however, in controlled trials, only 30-40% ...
... Jan. 6, 2011 Vista Partners announced today ... (Nasdaq: OPXA ) and raised its twelve ... Analyst at Vista Partners stated, "Opexa announced yesterday that their ... treatment of Multiple sclerosis , is now positioned from ...
... 2011 GENFIT (Alternext: ALGFT; ISIN: FR0004163111), a biopharmaceutical ... focusing on the early diagnosis and preventive treatment of ... two U.S. events: the 28th J.P. Morgan Healthcare Conference ... Showcase (from January 10th to 12th, 2011). ...
Cached Biology Technology:Ardea Biosciences Announces Positive Top-Line Results from Phase 2b Combination Study of RDEA594 in Allopurinol-Refractory Gout Patients 2Ardea Biosciences Announces Positive Top-Line Results from Phase 2b Combination Study of RDEA594 in Allopurinol-Refractory Gout Patients 3Ardea Biosciences Announces Positive Top-Line Results from Phase 2b Combination Study of RDEA594 in Allopurinol-Refractory Gout Patients 4Ardea Biosciences Announces Positive Top-Line Results from Phase 2b Combination Study of RDEA594 in Allopurinol-Refractory Gout Patients 5Ardea Biosciences Announces Positive Top-Line Results from Phase 2b Combination Study of RDEA594 in Allopurinol-Refractory Gout Patients 6Ardea Biosciences Announces Positive Top-Line Results from Phase 2b Combination Study of RDEA594 in Allopurinol-Refractory Gout Patients 7Vista Partners Updates Coverage on Opexa Therapeutics, Inc.; Raises Target Price From $4.40 to $6.50 2GENFIT: Strong U.S. Exposure for Its Biomarker Activity 2GENFIT: Strong U.S. Exposure for Its Biomarker Activity 3
(Date:7/2/2015)... Fingerprint Cards has received an order ... from the distributor World Peace Industrial Group (WPI), part of ... Asia . Deliveries are planned to take place ... by smartphone manufacturers in Asia . The ... revenue guidance of approximately 2,200 MSEK for 2015. ...
(Date:6/25/2015)... 2015 According to a ... & Area), Technology, Material (Optical Prism, Piezoelectric, Capacitive ... & Others) & Geography - Global Forecast to ... market is expected to reach $14,500.07 Million by ... Browse 76 market Tables and 109 Figures ...
(Date:6/24/2015)... 24, 2015  Synaptics Inc. (NASDAQ: SYNA ... today announced that Sharp has selected its industry-leading ... for its latest flagship smartphone device, the AQUOS ... million shipments of its fingerprint ID sensor technology, ... scalability and leadership in the biometrics market through ...
Breaking Biology News(10 mins):FPC Receives Order for Touch Fingerprint Sensors of 268 MSEK 2Fingerprint Sensors Market Worth $14,500.07 Million by 2020 2Fingerprint Sensors Market Worth $14,500.07 Million by 2020 3Fingerprint Sensors Market Worth $14,500.07 Million by 2020 4Synaptics Brings Natural ID Technology to Sharp's Newest Flagship Smartphone 2
... British Columbia researchers have identified a small virus that ... size, rescuing the infected zooplankton from certain death. The ... jumping genes found in other organisms. The study, ... Matthias Fischer, is published online today in Science Express. ...
... at managing environmental impacts of agriculture have spurred ... and natural fertilizers for commercial applications. Many organic ... other processing industries. In Mississippi, where the poultry ... each year, and annual chicken litter production is ...
... New University of Georgia research has identified a protein ... of the most common drugs used to treat pancreatic cancer. ... journal Cancer Research, found that a cell-surface protein ... reduced in function in two thirds of pancreatic tumors. By ...
Cached Biology News:'David and Goliath' viruses shed light on the origin of jumping genes: UBC study 2Chicken litter provides organic alternative to synthetic fertilizers 2Researchers find possible new treatment strategies for pancreatic cancer 2
4-Hydroxy-3-iodo-5-nitrophenylacetyl hapten is conjugated to BSA protein through lysine by amide bonds....
5,6 Carboxyfluorescein is conjugated to BSA (bovine serum albumin) protein through amide bonds....
... Edwards (1996) • Provides key ... immunoassays, including RIA, ELISA and ... the photoluminescent and chemiluminescent labels ... also given on assay design ...
... and M.W. Turner (1997). ... step-by-step methods for the ... molecules, the use of ... analytical probes and as ...
Biology Products: